Clinical trial
Testosterone and Myocardial Perfusion in Coronary Heart Disease (CHD)
NCT00239590 · Imperial College London, Other · Completed
Key facts
| NCT number | NCT00239590 |
|---|---|
| Title | Testosterone and Myocardial Perfusion in Coronary Heart Disease (CHD) |
| Official title | Effects of Chronic Testosterone on Myocardial Ischaemia and Endothelial Function in Men With Documented Coronary Heart Disease |
| Lead sponsor | Imperial College London, Other |
| Collaborators | Organon Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Coronary Heart Disease |
| Intervention type | Drug |
| Interventions | Testosterone undecanoate |
| Enrollment | 28 |
| Start date | Jun 1, 2001 |
| Primary completion | Apr 24, 2004 |
| Completion | Apr 24, 2004 |
| First posted | Oct 17, 2005 |
| Last update posted | Sep 25, 2019 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: